Please login to the form below

Not currently logged in
Email:
Password:

Actinium appoints director of clinical operations

Gregory Bergonio brings experience from Novartis

New York, US-based Actinium Pharmaceuticals has appointed Gregory Bergonio as director of clinical operations, with particular responsibility for its Actimab-A phase II clinical trial programme.

Bergonio moves from Novartis, where he served as an expert clinical manager in the Swiss firm's oncology global development unit, specialising in acute myeloid leukaemia.

Prior to this, Bergonio held a number of clinical research management positions at Bausch & Lomb, OSI Eyetech, Forest Laboratories, i3 Research and Kern McNeil.

Sandesh Seth, Actinium's executive chairman, said: “We are very excited to welcome Greg to the clinical development team at Actinium.

“Greg's joining comes at an ideal time given our increased development efforts as a result of the Actimab-A phase II trial and Iomab-B pivotal phase III SIERRA trial.

“Greg's direct experience in AML and significant knowledge of clinical trial management will have an immediate impact on our capabilities that we expect will add efficiency and scale to our current and planned clinical development efforts.”

5th January 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...